NCT04614103 2025-11-12Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerIovance Biotherapeutics, Inc.Phase 2 Recruiting170 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT06528418 2025-03-26Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathChromX HealthRecruiting10,000 enrolled
NCT05361174 2024-12-05A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerIovance Biotherapeutics, Inc.Phase 1/2 Recruiting53 enrolled